M. Bader, Stefanie https://orcid.org/0000-0002-7901-9833
Scherer, Lena
Bhandari, Reet https://orcid.org/0000-0001-6625-8037
Motyer, Allan J.
Cooney, James P.
Mackiewicz, Liana https://orcid.org/0000-0002-4340-4975
Dayton, Merle
Sheerin, Dylan
V. L. Romero, David
Schaefer, Jan https://orcid.org/0000-0002-1432-4212
Pang, Jiyi
Chen, Siqi
Schoffer, Kael
Wang, Le
Jin, Xinyi
Batey, Daniel
Yip, Raymond K. H. https://orcid.org/0000-0003-2698-7686
Zaman, Ishrat
Rajasekhar, Pradeep https://orcid.org/0000-0002-1983-7244
Gartner, Matthew J.
Wilcox, Stephen
Whitehead, Lachlan https://orcid.org/0000-0002-4388-9642
Georgy, Smitha Rose https://orcid.org/0000-0003-4716-8559
Maluenda, Ana
Davidson, Kathryn C.
Allison, Cody C.
Bowden, Rory https://orcid.org/0000-0001-8596-0366
Brinkmann, Kerstin https://orcid.org/0000-0002-9411-6674
Asselin-Labat, Marie-Liesse https://orcid.org/0000-0001-7082-6076
Phipson, Belinda https://orcid.org/0000-0002-1711-7454
Tanzer, Maria C. https://orcid.org/0000-0002-4657-9869
Herold, Marco J. https://orcid.org/0000-0001-7539-7581
Samson, Andre L. https://orcid.org/0000-0002-0637-2716
Vince, James E. https://orcid.org/0000-0001-7166-2798
Strasser, Andreas https://orcid.org/0000-0002-5020-4891
Pellegrini, Marc
Doerflinger, Marcel https://orcid.org/0000-0001-9159-3021
Funding for this research was provided by:
Bellberry-Viertel Senior Medical Research Fellowship
Department of Health | National Health and Medical Research Council (2008692, 1183070)
Department of Health | National Health and Medical Research Council (1020363)
Department of Health | National Health and Medical Research Council (GNT1175011)
Victorian Government Department of Health and Human Services ‘Victorian COVID-19 Research Fund’; The MAWA trust - developing alternatives to animal research
Article History
Received: 13 November 2024
Accepted: 7 October 2025
First Online: 13 November 2025
Competing interests
: A.S. is a consultant for Dimericon which are generating compounds to modulate the functions of caspase-8 and FLIP. A.L.S. has contributed to the development of necroptosis pathway inhibitors in collaboration with Anaxis Pharma Pty Ltd. The other authors declare no competing interests relating to this work.